U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
allogeneic CD4+ and CD8+ T lymphocytes derived from leukapheresis material of healthy donors, genetically modified using CRISPR/Cas9 gene editing to knockout the expression of endogenous CD7 and TRAC using inactivating, non-replicating lentivirus vector
Preferred Name English
Soficabtagene Geleucel
INN  
Official Name English
soficabtagene geleucel [INN]
Common Name English
Code System Code Type Description
FDA UNII
Z75Y8V4FFA
Created by admin on Wed Apr 02 20:56:24 GMT 2025 , Edited by admin on Wed Apr 02 20:56:24 GMT 2025
PRIMARY
INN
13448
Created by admin on Wed Apr 02 20:56:24 GMT 2025 , Edited by admin on Wed Apr 02 20:56:24 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966